FN1 and pulmonary hypertension, primary, 1: Our findings raise two pivotal translational questions: (1) What is the mechanistic basis for FN-mediated lymphangiogenesis suppression, and (2) Does lymphatic inhibition compromise the therapeutic efficacy of FN in PHT?